Losing weight can often seem like an uphill battle, especially if you're trying to get rid of stubborn abdominal fat that ...

Novo Nordisk’s stock tumbles after its oral GLP-1 drug didn’t show a statistically significant benefit over a placebo against ...

“The human body absorbs allulose but instead of breaking it down for energy, it eliminates most of it unchanged via waste.

Type 2 diabetes, a disease in which your body cannot make enough insulin or does not properly use the insulin it makes, ...

Eli Lilly posts 54% revenue growth, raises guidance, and drives innovation in obesity and diabetes care. Read here for an ...

While Novo Nordisk and Pfizer intensify their plays, Lilly’s early lead in GLP-1 treatments has put it in a category all its ...

Ultra-processed foods are convenient choices, but they have a negative impact on your health. Learn what they are and how to make healthier choices.

About 4 in 10 of the more than 42 million Americans who get Supplemental Nutrition Assistance Program benefits are children ...

KKCTH educates families on carb counting for better insulin management in children with type-1 diabetes during World Diabetes Day events.

Blood sugar fluctuations are normal, but in people with diabetes, who don't produce enough insulin, blood sugar spikes and ...

Novo Nordisk remains a dominant business with a strong pipeline, and current multiples are low enough to justify a buy. Read my latest analysis of NVO stock.

Dietitians are not just end-users of AI tools. They can be cocreators, leaders, and subject matter experts on AI projects. In ...